GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transcenta Holding Ltd (HKSE:06628) » Definitions » Other Stockholders Equity

Transcenta Holding (HKSE:06628) Other Stockholders Equity : HK$-108.11 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Transcenta Holding Other Stockholders Equity?

Transcenta Holding's Other Stockholders Equity for the quarter that ended in Dec. 2024 was HK$-108.11 Mil.

Transcenta Holding's quarterly Other Stockholders Equity increased from Dec. 2023 (HK$-132.50 Mil) to Jun. 2024 (HK$-118.22 Mil) and increased from Jun. 2024 (HK$-118.22 Mil) to Dec. 2024 (HK$-108.11 Mil).

Transcenta Holding's annual Other Stockholders Equity increased from Dec. 2022 (HK$-162.81 Mil) to Dec. 2023 (HK$-132.50 Mil) and increased from Dec. 2023 (HK$-132.50 Mil) to Dec. 2024 (HK$-108.11 Mil).


Transcenta Holding Other Stockholders Equity Historical Data

The historical data trend for Transcenta Holding's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transcenta Holding Other Stockholders Equity Chart

Transcenta Holding Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Stockholders Equity
Get a 7-Day Free Trial -967.68 2,406.43 -162.81 -132.50 -108.11

Transcenta Holding Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -162.81 -153.78 -132.50 -118.22 -108.11

Transcenta Holding Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Transcenta Holding Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Transcenta Holding's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Transcenta Holding Business Description

Traded in Other Exchanges
N/A
Address
B6-501, 218 Xinghu Street, Biobay, Suzhou, CHN, 215123
Transcenta Holding Ltd is a clinical-stage biopharmaceutical company with fully integrated capacities in discovery, research, development, and manufacturing. It is developing nine therapeutic antibody molecules for oncology and selected non-oncology indications including bone and kidney disorders. Geographically the company operates in China (the PRC) and the USA.
Executives
Qian Xueming 2101 Beneficial owner
Shi Xiaohong 2501 Other
Lav Corporate Gp, Ltd. 2201 Interest of corporation controlled by you
Lav Gp Iii, L.p. 2201 Interest of corporation controlled by you
Lav Biosciences Fund Iii, L.p. 2101 Beneficial owner
Shi Yi 2201 Interest of corporation controlled by you
Lav Asset Management (hong Kong) Limited 2102 Investment manager
Fullerton Management Pte Ltd
Temasek Life Sciences Private Limited
Tls Beta Pte. Ltd.
Hsbc Trust Company (delaware), N.a. 2301 Trustee
Success Link International L.p. 2101 Beneficial owner
Temasek Holdings (private) Limited
Lav Vitality Limited 2101 Beneficial owner
Zhong Guo Guo You Qi Ye Jie Gou Tiao Zheng Ji Jin Gu Fen You Xian Gong Si 2501 Other

Transcenta Holding Headlines

No Headlines